BEAM
Price
$15.25
Change
-$1.21 (-7.35%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
1.52B
38 days until earnings call
TLPPF
Price
$16.05
Change
-$0.14 (-0.86%)
Updated
Apr 3 closing price
Capitalization
4.95B
Ad is loading...

BEAM vs TLPPF

Header iconBEAM vs TLPPF Comparison
Open Charts BEAM vs TLPPFBanner chart's image
Beam Therapeutics
Price$15.25
Change-$1.21 (-7.35%)
Volume$88.26K
Capitalization1.52B
Telix Pharmaceutical
Price$16.05
Change-$0.14 (-0.86%)
Volume$404
Capitalization4.95B
BEAM vs TLPPF Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. TLPPF commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and TLPPF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (BEAM: $16.46 vs. TLPPF: $16.05)
Brand notoriety: BEAM and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 171% vs. TLPPF: 11%
Market capitalization -- BEAM: $1.52B vs. TLPPF: $5.38B
BEAM [@Biotechnology] is valued at $1.52B. TLPPF’s [@Biotechnology] market capitalization is $5.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, TLPPF is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish.

  • BEAM’s TA Score: 4 bullish, 5 bearish.

Price Growth

BEAM (@Biotechnology) experienced а -25.82% price change this week, while TLPPF (@Biotechnology) price change was -15.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($4.95B) has a higher market cap than BEAM($1.53B). TLPPF YTD gains are higher at: 7.179 vs. BEAM (-33.629). TLPPF has higher annual earnings (EBITDA): 92.5M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. TLPPF (710M). BEAM has less debt than TLPPF: BEAM (161M) vs TLPPF (581M). TLPPF has higher revenues than BEAM: TLPPF (783M) vs BEAM (63.5M).
BEAMTLPPFBEAM / TLPPF
Capitalization1.53B4.95B31%
EBITDA-383.98M92.5M-415%
Gain YTD-33.6297.179-468%
P/E RatioN/A150.77-
Revenue63.5M783M8%
Total Cash851M710M120%
Total Debt161M581M28%
TECHNICAL ANALYSIS
Technical Analysis
BEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GFVRX15.15N/A
N/A
Goldman Sachs Focused Value R
MVCAX30.26N/A
N/A
MFS Mid Cap Value A
SZCAX47.39N/A
N/A
DWS Small Cap Core A
FMCRX14.71N/A
N/A
Federated Hermes Mid-Cap Index IS
MSMJX28.14N/A
N/A
Invesco Main Street Mid Cap R5

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-10.93%
CRSP - BEAM
73%
Closely correlated
-4.47%
NTLA - BEAM
63%
Loosely correlated
-5.62%
RXRX - BEAM
62%
Loosely correlated
-9.07%
DNLI - BEAM
57%
Loosely correlated
-6.91%
PRME - BEAM
57%
Loosely correlated
-10.06%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and GLMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
-0.88%
GLMD - TLPPF
25%
Poorly correlated
-2.67%
DNLI - TLPPF
24%
Poorly correlated
-6.91%
BEAM - TLPPF
24%
Poorly correlated
-10.93%
RXRX - TLPPF
23%
Poorly correlated
-9.07%
JANX - TLPPF
23%
Poorly correlated
-4.46%
More